Compare HAL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAL | WST |
|---|---|---|
| Founded | 1919 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4B | 20.2B |
| IPO Year | N/A | N/A |
| Metric | HAL | WST |
|---|---|---|
| Price | $27.79 | $271.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | $32.06 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 11.4M | 742.7K |
| Earning Date | 01-21-2026 | 10-23-2025 |
| Dividend Yield | ★ 2.45% | 0.32% |
| EPS Growth | N/A | ★ 0.17 |
| EPS | 1.52 | ★ 6.75 |
| Revenue | ★ $22,137,000,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | ★ $18.29 | $40.37 |
| Revenue Growth | N/A | ★ 4.92 |
| 52 Week Low | $18.72 | $187.43 |
| 52 Week High | $30.40 | $348.90 |
| Indicator | HAL | WST |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 49.85 |
| Support Level | $26.79 | $264.92 |
| Resistance Level | $29.67 | $275.56 |
| Average True Range (ATR) | 0.81 | 7.46 |
| MACD | -0.11 | -0.37 |
| Stochastic Oscillator | 45.79 | 35.88 |
Halliburton is North America's largest oilfield-services company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. Halliburton's innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been honed over a century of operations.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.